{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:16:03Z","timestamp":1790136963319,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    More than half of preterm births are triggered by inflammatory processes at the foeto-maternal interface. These inflammatory processes can persist after birth due to the unique vulnerabilities of preterm infants, often resulting in sustained inflammation with a role in complications such as bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH), and periventricular leukomalacia (PVL). The aim of this study was to evaluate the predictive value of maternal inflammatory status, assessed through biomarkers of inflammation (CRP, chorioamnionitis, preeclampsia), and neonatal inflammatory markers (CRP 1, CRP 2, PCT, IL3, MMP9) on the incidence of NEC in preterm neonates. We conducted a prospective longitudinal study in the 1st Neonatology Department, Cluj-Napoca, Romania. A total of 82 preterm newborns (gestational age\u2009&lt;\u200934\u00a0weeks\u2009+\u20096\u00a0days) were enrolled in the study. Interleukin-3 (IL3) and matrix metalloproteinase-9 (MMP9) levels were measured using the ELISA technique. Additionally, C-reactive protein (CRP) and procalcitonin (PCT) were measured in the first days of life. The correlation between these inflammatory markers and the incidence of NEC was analyzed. Furthermore, we examined the role of maternal inflammation and chorioamnionitis in relation to NEC incidence. Out of the 82 neonates enrolled, 20 developed NEC. Neonates who developed NEC had higher IL3 levels at birth. A significant positive correlation was found between maternal CRP levels and neonatal IL3 levels (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.541,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). In the NEC group, maternal CRP levels were also elevated compared to those in neonates who did not develop NEC.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : Neonatal inflammation is associated with an increased incidence of NEC. Prenatal inflammatory conditions appear to trigger a persistent inflammatory process in preterm neonates, raising the risk of NEC.\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              <jats:italic>\u2022 NEC is a multifactorial disease of preterm newborn with multiple maternal and neonatal risk factors.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              <jats:italic>\u2022 Evaluate the probability of NEC at preterm neonates of mothers with ongoing inflammatory conditions during pregnancy.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-025-06146-0","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T15:09:55Z","timestamp":1745852995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The predictive value of maternal and neonatal inflammatory biomarkers for necrotizing enterocolitis"],"prefix":"10.1007","volume":"184","author":[{"given":"Melinda","family":"Matyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Ily\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalina","family":"Valeanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M","family":"Cr\u0103ciun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"H\u0103\u0219m\u0103\u0219anu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoleta","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Zaharie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"6146_CR1","doi-asserted-by":"publisher","unstructured":"Zozaya C et al. (2020) Incidence, treatment, and outcome trends of necrotizing enterocolitis in preterm infants: a multicenter cohort study. Front Pediatr. https:\/\/doi.org\/10.3389\/FPED.2020.00188","DOI":"10.3389\/FPED.2020.00188"},{"key":"6146_CR2","doi-asserted-by":"publisher","unstructured":"Klerk DH et al. (2024) Core outcome set for necrotizing enterocolitis treatment trials. Pediatrics 153(6). https:\/\/doi.org\/10.1542\/PEDS.2023-065619","DOI":"10.1542\/PEDS.2023-065619"},{"key":"6146_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/J.EARLHUMDEV.2016.12.002","volume":"105","author":"M Gilfillan","year":"2017","unstructured":"Gilfillan M, Bhandari V (2017) Biomarkers for the diagnosis of neonatal sepsis and necrotizing enterocolitis: clinical practice guidelines. Early Hum Dev 105:25\u201333. https:\/\/doi.org\/10.1016\/J.EARLHUMDEV.2016.12.002","journal-title":"Early Hum Dev"},{"issue":"6","key":"6146_CR4","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1097\/MPG.0000000000001588","volume":"65","author":"G Terrin","year":"2017","unstructured":"Terrin G, Stronati L, Cucchiara S, De Curtis M (2017) Serum markers of necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr 65(6):e120\u2013e132. https:\/\/doi.org\/10.1097\/MPG.0000000000001588","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"6146_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/JAMAPEDIATRICS.2016.2708","volume":"171","author":"BL Frost","year":"2017","unstructured":"Frost BL, Modi BP, Jaksic T, Caplan MS (2017) New medical and surgical insights into neonatal necrotizing enterocolitis: a review. JAMA Pediatr 171(1):83\u201388. https:\/\/doi.org\/10.1001\/JAMAPEDIATRICS.2016.2708","journal-title":"JAMA Pediatr"},{"key":"6146_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/J.JPEDS.2019.11.011","volume":"220","author":"IH Jones","year":"2020","unstructured":"Jones IH, Hall NJ (2020) Contemporary outcomes for infants with necrotizing enterocolitis-a systematic review. J Pediatr 220:86-92.e3. https:\/\/doi.org\/10.1016\/J.JPEDS.2019.11.011","journal-title":"J Pediatr"},{"key":"6146_CR7","doi-asserted-by":"publisher","unstructured":"Matyas M et al. (2022) Early preeclampsia effect on preterm newborns outcome. J Clin Med 11(2). https:\/\/doi.org\/10.3390\/JCM11020452","DOI":"10.3390\/JCM11020452"},{"key":"6146_CR8","doi-asserted-by":"publisher","unstructured":"Canvasser J et al. (2023) Long-term outcomes and life-impacts of necrotizing enterocolitis: a survey of survivors and parents. Semin Perinatol 47(1). https:\/\/doi.org\/10.1016\/J.SEMPERI.2022.151696","DOI":"10.1016\/J.SEMPERI.2022.151696"},{"issue":"4","key":"6146_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1136\/ARCHDISCHILD-2019-317830","volume":"105","author":"A Matei","year":"2020","unstructured":"Matei A, Montalva L, Goodbaum A, Lauriti G, Zani A (2020) Neurodevelopmental impairment in necrotising enterocolitis survivors: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 105(4):432\u2013439. https:\/\/doi.org\/10.1136\/ARCHDISCHILD-2019-317830","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"7","key":"6146_CR10","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/BRAINSCI13071094","volume":"13","author":"S Ilu\u0163","year":"2023","unstructured":"Ilu\u021b S, Vesa \u015eC, V\u0103c\u0103ra\u0219 V, Br\u0103i\u021b\u0103 L, D\u0103sc\u0103lescu VC, Fantu I, Mure\u0219anu DF (2023) Biological risk factors influencing vascular cognitive impairments: a review of the evidence. Brain Sci 13(7):1094. https:\/\/doi.org\/10.3390\/BRAINSCI13071094","journal-title":"Brain Sci"},{"issue":"3","key":"6146_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.15586\/JPTCP.V26I3.602","volume":"26","author":"MS Elfarargy","year":"2019","unstructured":"Elfarargy MS, Atef MM, El-Deeb OS, Elsharaby RM, Elhady HAE (2019) Early biomarkers in neonatal necrotizing enterocolitis: a pilot study. J Popul Ther Clin Pharmacol 26(3):e1\u2013e8. https:\/\/doi.org\/10.15586\/JPTCP.V26I3.602","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"4","key":"6146_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/S00011-023-01702-6","volume":"72","author":"H Dong","year":"2023","unstructured":"Dong H, Zhang L, Li B, Li J, Chen Y, Richard SA, Xu Y, Zhu C (2023) Screening inflammatory protein biomarkers on premature infants with necrotizing enterocolitis. Inflamm Res 72(4):757\u2013768. https:\/\/doi.org\/10.1007\/S00011-023-01702-6","journal-title":"Inflamm Res"},{"issue":"2","key":"6146_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/MIB.0000000000000658","volume":"22","author":"C H\u00e4rtel","year":"2016","unstructured":"H\u00e4rtel C et al (2016) NOD2 loss-of-function mutations and risks of necrotizing enterocolitis or focal intestinal perforation in very low-birth-weight infants. Inflamm Bowel Dis 22(2):249\u2013256. https:\/\/doi.org\/10.1097\/MIB.0000000000000658","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"6146_CR14","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.jpedsurg.2011.03.069","volume":"46","author":"M \u00c7etinkaya","year":"2011","unstructured":"\u00c7etinkaya M, \u00d6zkan H, K\u00f6ksal N, Akaci O, \u00d6zg\u00fcr T (2011) Comparison of the efficacy of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants. J Pediatr Surg 46(8):1482\u20131489. https:\/\/doi.org\/10.1016\/j.jpedsurg.2011.03.069","journal-title":"J Pediatr Surg"},{"issue":"11","key":"6146_CR15","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1007\/S10620-007-9763-Y","volume":"52","author":"D Turner","year":"2007","unstructured":"Turner D et al (2007) Low levels of procalcitonin during episodes of necrotizing enterocolitis. Dig Dis Sci 52(11):2972\u20132976. https:\/\/doi.org\/10.1007\/S10620-007-9763-Y","journal-title":"Dig Dis Sci"},{"issue":"6","key":"6146_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/J.SINY.2018.07.006","volume":"23","author":"PC Ng","year":"2018","unstructured":"Ng PC (2018) An update on biomarkers of necrotizing enterocolitis. Semin Fetal Neonatal Med 23(6):380\u2013386. https:\/\/doi.org\/10.1016\/J.SINY.2018.07.006","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"6146_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/J.JCMGH.2018.04.001","volume":"6","author":"DJ Hackam","year":"2018","unstructured":"Hackam DJ, Sodhi CP (2018) Toll-like receptor-mediated intestinal inflammatory imbalance in the pathogenesis of necrotizing enterocolitis. Cell Mol Gastroenterol Hepatol 6(2):229-238.e1. https:\/\/doi.org\/10.1016\/J.JCMGH.2018.04.001","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"6146_CR18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3892\/ETM.2017.5532","volume":"15","author":"Z Li","year":"2017","unstructured":"Li Z, Sheng L (2017) Significance of dynamic evolution of TNF-\u03b1, IL-6 and intestinal fatty acid-binding protein levels in neonatal necrotizing enterocolitis. Exp Ther Med 15(2):1289. https:\/\/doi.org\/10.3892\/ETM.2017.5532","journal-title":"Exp Ther Med"},{"issue":"22","key":"6146_CR19","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1080\/14767058.2017.1361925","volume":"31","author":"BD Garg","year":"2018","unstructured":"Garg BD, Sharma D, Bansal A (2018) Biomarkers of necrotizing enterocolitis: a review of literature. J Matern Fetal Neonatal Med 31(22):3051\u20133064. https:\/\/doi.org\/10.1080\/14767058.2017.1361925","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"6146_CR20","doi-asserted-by":"publisher","first-page":"8413698","DOI":"10.1155\/2019\/8413698","volume":"2019","author":"K Wang","year":"2019","unstructured":"Wang K, Tao G, Sun Z, Sylvester KG (2019) Recent potential noninvasive biomarkers in necrotizing enterocolitis. Gastroenterol Res Pract 2019(1):8413698. https:\/\/doi.org\/10.1155\/2019\/8413698","journal-title":"Gastroenterol Res Pract"},{"key":"6146_CR21","doi-asserted-by":"publisher","unstructured":"Moonen RM, Huizing MJ, Gonz\u00e1lez-Luis GE, Cavallaro G, Mosca F, Villamor E (2020) Risk of necrotizing enterocolitis associated with the single nucleotide polymorphisms VEGF C-2578A, IL-18 C-607A, and IL-4 receptor \u03b1 -chain A-1902G: a validation study in a prospective multicenter cohort. Front Pediatr 8. https:\/\/doi.org\/10.3389\/FPED.2020.00045","DOI":"10.3389\/FPED.2020.00045"},{"issue":"7","key":"6146_CR22","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3390\/MICROORGANISMS10071382","volume":"10","author":"KY Burge","year":"2022","unstructured":"Burge KY, Markel TA (2022) Neonatal microbiome, intestinal inflammation, and necrotizing enterocolitis. Microorganisms 10(7):1382. https:\/\/doi.org\/10.3390\/MICROORGANISMS10071382","journal-title":"Microorganisms"},{"key":"6146_CR23","doi-asserted-by":"publisher","unstructured":"Shores DR et al. (2020) Normative values for circulating intestinal fatty acid binding protein and calprotectin across gestational ages. BMC Pediatr 20(1). https:\/\/doi.org\/10.1186\/S12887-020-02142-5","DOI":"10.1186\/S12887-020-02142-5"},{"issue":"4","key":"6146_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/S00281-020-00803-2","volume":"42","author":"A Humberg","year":"2020","unstructured":"Humberg A et al (2020) Preterm birth and sustained inflammation: consequences for the neonate. Semin Immunopathol 42(4):451\u2013468. https:\/\/doi.org\/10.1007\/S00281-020-00803-2","journal-title":"Semin Immunopathol"},{"key":"6146_CR25","doi-asserted-by":"publisher","unstructured":"Sampah MES, Hackam DJ (2020) Dysregulated mucosal immunity and associated pathogeneses in preterm neonates. Front Immunol 11. https:\/\/doi.org\/10.3389\/FIMMU.2020.00899","DOI":"10.3389\/FIMMU.2020.00899"},{"key":"6146_CR26","doi-asserted-by":"publisher","unstructured":"Pan X et al. (2020) Postnatal gut immunity and microbiota development is minimally affected by prenatal inflammation in preterm pigs. Front Immunol 11. https:\/\/doi.org\/10.3389\/FIMMU.2020.00420","DOI":"10.3389\/FIMMU.2020.00420"},{"issue":"11","key":"6146_CR27","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/J.JPEDSURG.2009.07.028","volume":"44","author":"N Evennett","year":"2009","unstructured":"Evennett N, Alexander N, Petrov M, Pierro A, Eaton S (2009) A systematic review of serologic tests in the diagnosis of necrotizing enterocolitis. J Pediatr Surg 44(11):2192\u20132201. https:\/\/doi.org\/10.1016\/J.JPEDSURG.2009.07.028","journal-title":"J Pediatr Surg"},{"issue":"1","key":"6146_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/J.CLP.2021.11.011","volume":"49","author":"A Gunasekaran","year":"2022","unstructured":"Gunasekaran A, Devette C, Levin S, Chaaban H (2022) Biomarkers of necrotizing enterocolitis: the search continues. Clin Perinatol 49(1):181\u2013194. https:\/\/doi.org\/10.1016\/J.CLP.2021.11.011","journal-title":"Clin Perinatol"},{"key":"6146_CR29","doi-asserted-by":"publisher","unstructured":"Agakidou E, Agakidis C, Gika H, Sarafidis K (2020) Emerging biomarkers for prediction and early diagnosis of necrotizing enterocolitis in the era of metabolomics and proteomics. Front Pediatr 8. https:\/\/doi.org\/10.3389\/FPED.2020.602255","DOI":"10.3389\/FPED.2020.602255"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06146-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06146-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06146-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T16:03:14Z","timestamp":1746892994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06146-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["6146"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06146-0","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University of Medicine and Pharmacy Cluj Napoca, Romania (Date 25.05.2022\/No.127).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"316"}}